Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

BACKGROUND: The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find protein markers in cerebrospinal fluid (CSF) from patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Remnestål, Julia, Öijerstedt, Linn, Ullgren, Abbe, Olofsson, Jennie, Bergström, Sofia, Kultima, Kim, Ingelsson, Martin, Kilander, Lena, Uhlén, Mathias, Månberg, Anna, Graff, Caroline, Nilsson, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310563/
https://www.ncbi.nlm.nih.gov/pubmed/32576262
http://dx.doi.org/10.1186/s40035-020-00198-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310563/
https://www.ncbi.nlm.nih.gov/pubmed/32576262
http://dx.doi.org/10.1186/s40035-020-00198-y

Ejemplares similares